GBP
Blog
Health support
Products on demand
Sport and fitness
Clear filters

Brain Vitamins Against Dementia

Vitamin360
Vitamin360
09/01/2026 10:29

Dementia is far more than a simple memory disorder. It is a complex neurodegenerative condition whose exact mechanisms are still surrounded by many unanswered questions. Advancing age is one of the most significant risk factors in its development. When we take a closer look, it becomes clear that increasing life expectancy in the modern world is a double-edged sword: on the one hand, it is a remarkable achievement that we are living longer; on the other, the number of people affected by dementia continues to rise steadily. According to projections, by the middle of this century the prevalence of the condition could even triple.¹˒²

This article does not aim to offer a cure for dementia. Instead, it seeks to highlight how certain lifestyle factors and dietary supplements may help reduce the risk of its onset. Our focus is on so-called “brain vitamins” – natural compounds and nutrients that may support brain health, help maintain cognitive function, and contribute to long-term mental sharpness.

An elderly man shown in multiple blurred overlays, symbolizing memory loss or cognitive decline

What is Dementia?

Although the term dementia is now considered outdated, experts prefer the designation major neurocognitive disorder (MND), as it more accurately reflects the diverse background and clinical variability of the condition. MND is not merely “senility,” but a widespread decline in the nervous system.3

The concept encompasses changes caused by protein accumulations (e.g., dementia associated with Alzheimer’s, Huntington’s, or Parkinson’s disease), as well as vascular origins (e.g., post-infarction), infection-related (e.g., HIV), or those resulting from substance use.4

Behind protein accumulations lie inflammatory cell damage and genetic factors, while a common feature of vascular, infectious, and substance-induced dementias is the presence of inflammatory processes.5,6

Why Does Aging Predispose Us to It?

All the aforementioned contributing factors intensify with advancing age. Why?

  • In older age, atherosclerosis, high blood pressure, and small cerebral infarcts are more common, impairing brain blood supply and promoting vascular dementia. This may be accompanied by diabetes and other cardiovascular diseases, further increasing risk.9
  • During aging, the synthesis of faulty proteins (e.g., beta-amyloid and tau) increases. This is accompanied by inflammation and a self-reinforcing process that predisposes to protein accumulation.8
  • Gradual neuron loss and diminished brain regenerative capacity are also hallmarks of old age. In Alzheimer’s disease, for instance, a significant portion of neurons (up to 50–60%) may die unnoticed before clinical symptoms appear.7

Why Do Brain Training and Exercise Help?

Numerous studies confirm that dementia develops less frequently among those who regularly engage in intellectual work or active sports.10-14

Memory games, puzzles, language learning, math tasks — or mastering any new skill — create neural connections that previously did not exist. This allows the brain to adapt more flexibly to damage and maintain functionality longer.

Physical activity improves cerebral blood flow, reduces inflammatory processes, and stimulates new neuron formation in the hippocampus (the memory center).

Intellectual and physical training together increase the so-called “cognitive reserve,” a “protective shield” that delays symptom onset even if pathological changes are already underway in the brain.

Cognitive Reserve: Let’s Explore This in Detail

The concept of “cognitive reserve” entered scientific thinking in the late 1980s and early 1990s, primarily through the work of Yaakov Stern and colleagues. Its essence is that the brain can compensate for damage and pathological changes if we build sufficient “reserve” through learning, intellectual activity, work, and social connections over our lifetime.15-18

Thus, the body uses alternative neural networks to counteract symptoms after certain injuries. This explains, among other things, why certain diseases can cause symptoms independently of their severity. For example, two individuals may show similar Alzheimer-like changes, but symptoms appear later in one because they possess greater cognitive reserve.

Yaakov Stern’s observations are corroborated by several key studies reporting that education and intellectual activity delay the onset of clinical symptoms.16-18 Furthermore, meta-analyses confirm that the protective effect of cognitive reserve is statistically significant.

What Stimulates Cognitive Reserve?

An elderly couple embracing warmly, smiling happily

As previously touched upon, cognitive reserve is stimulated not by a single factor but by a combination of lifestyle habits: learning, intellectual challenges, regular exercise, social connections, and healthy living. Together, these build the “protective shield” that delays the emergence of dementia symptoms.

In terms of diet, researchers have found that nutrition rich in antioxidants and omega-3 fatty acids moderates inflammation and protects neurons.19,20

Cortisol (the stress hormone) impairs the development of cognitive reserve. Proper stress management techniques (mindfulness, yoga) reduce cortisol’s harmful effects, thereby enhancing cognitive reserve.21-23

Perhaps one of the most undervalued factors is sleep. Memory consolidation is closely linked to the concept of cognitive reserve: when we learn something new, new connections (synapses) form between neurons. During sleep, these connections strengthen, information organizes, and becomes durable — this is memory consolidation. Thus, sleep not only serves rest but actively contributes to maintaining the brain’s resilience and long-term function.24,25

What Biochemical Processes Regulate Cognitive Reserve?

The formation of cognitive reserve requires:

  • Strengthening connections between neurons — key “hormones” include acetylcholine (responsible for brain-muscle connections), serotonin (“happiness hormone”), and dopamine (reward hormone).
  • Formation of new neurons — key factors: BDNF (Brain-Derived Neurotrophic Factor) and NGF (Nerve Growth Factor).
  • Reducing inflammation — chronic inflammation impairs cognitive reserve. Inflammatory cytokines damage neurons. Anti-inflammatory agents can help prevent this.
  • Adequate antioxidant protection — free radicals also damage neurons. These toxins arise even from everyday biochemical processes. Antioxidants protect against oxidative stress, obtainable from diet or supplements.
  • Proper cellular metabolism — “Adequate brain energy supply is essential for preserving cognitive reserve, so the cells’ tiny “engines,” the mitochondria, must function healthily and efficiently. The good news is that certain natural compounds specifically support mitochondrial function, contributing to long-term nervous system protection.”

Dietary Supplements That May Strengthen Cognitive Reserve

Supplements supporting brain reserve include ginkgo biloba, panax ginseng, phosphatidylcholine, omega-3 fatty acids, various B vitamins, and antioxidants such as vitamins E and C.26-39 These compounds not only offer general neuroprotective properties but, according to studies, contribute to memory preservation, improved concentration, and flexible neural connections.

Their effects are exerted through one or more of the five pathways mentioned earlier (e.g., stimulating dopamine, regenerating neurons via NGF, reducing inflammation, antioxidant action, or mitochondrial support).

Which Dietary Supplements May Reduce Protein Accumulation?

As noted, dementia is often caused by protein aggregation. Currently, some medications and compounds in development specifically target dementia-related protein buildup, such as beta-amyloid and tau in Alzheimer’s or alpha-synuclein in Parkinson’s.

Among dietary supplement ingredients, some specifically reduce excessive protein production alongside whole-body effects. Naturally, their impact is not as strong as pharmaceuticals and does not replace them.

Research into natural compounds reducing protein aggregation began in the 1990s, with breakthroughs arriving in the early 2020s.

Let’s Review the Most Important Natural Compounds!

Epigallocatechin Gallate (EGCG) — green tea extract: Among the first plant compounds studied for dementia. Research shows it can transform Alzheimer-related beta-amyloid fibrils into a less toxic form, inhibiting accumulation. Studies used 400–800 mg/day EGCG.40-42

Curcumin — turmeric extract: Directly binds to beta-amyloid, inhibits plaque formation, and aids tau protein stabilization linked to Parkinson’s. Smaller clinical trials for Alzheimer’s used 2–4 g/day curcumin, though efficacy is not fully outlined. Better-absorbed forms may require less.43,44

Resveratrol — grape skin/red wine polyphenol: Activates the sirtuin-1 pathway, enhancing amyloid breakdown and inhibiting accumulation. Dosing varies widely due to low absorption; clinical trials often used 500 mg–1 g/day over months. A notable 2015 randomized trial gave Alzheimer’s patients 1 g/day, then 2 g/day resveratrol, showing influence on amyloid buildup, though side effects (e.g., gastrointestinal issues, weight loss) occurred at high doses.45-47

Omega-3 Fatty Acids (DHA, EPA) — fish oil, algae extract: Studies indicate DHA directly affects beta-amyloid metabolism and reduces tau phosphorylation. Trials examined 1–2 g DHA/day. Choose high-DHA fish oil supplements.48-50

Huperzine A: A Chinese plant alkaloid with unique effects. While others reduce beta-amyloid and tau aggregation, Huperzine A inhibits acetylcholinesterase, improving memory and learning.51-53

Conclusion

An elderly woman joyfully hugging her grandson on a couch

It is clear that numerous compounds can simultaneously moderate protein aggregation and support brain function. The reason is that these substances typically act through multiple mechanisms. Most plant-derived compounds, for example, also possess strong antioxidant and anti-inflammatory properties, thus comprehensively protecting the nervous system from damage.

Vitamin360’s Recommendations Based on This

NOW Foods Brain Elevate Cognitive Function Support: Contains a significant portion of the supplements listed above.

  • Ginkgo biloba extract improves cerebral circulation and acts as an antioxidant, supporting memory and concentration.
  • RoseOx® (rosemary extract) is a potent antioxidant protecting neurons from oxidative stress and contributing to long-term brain function stability.
  • Phosphatidylserine and choline are key components of cell membranes.
  • Huperzine supports memory via its effect on the acetylcholine neurotransmitter.

The product’s dosing is moderate, suitable for prevention and mild complaints, though higher doses may be needed for therapeutic purposes — always under medical advice.

NOW Foods Curcumin 400 mg Capsules — CurcuBrain: An absorption-optimized curcumin formula requiring significantly less for nervous system support.

NOW Foods DHA-500, Double Strength — Extra Potent Omega-3 Fatty Acids: This extra-strength omega-3 supplement, with high DHA (500 mg per capsule) and EPA (250 mg), supports brain function, cardiovascular health, and cellular protection.

USA Medical Green Tea Extract 50% EGCG: Contains green tea extract plus a touch of grape seed powder. Grape seed is rich in polyphenols and proanthocyanidins, potent antioxidants that synergize with EGCG to enhance cellular protection, circulation support, and nervous system defenses. The amount is minimal, serving only synergistic purposes.

Life Extension Optimized Resveratrol Elite™: Speaking of grapes! In this product, polyphenols work synergistically — resveratrol from red wine is enhanced by quercetin (aiding absorption). Quercetin also directly affects cellular mitochondria, promoting stable function and efficient energy use. As mentioned early in the article, mitochondrial health is crucial for dementia prevention.

NOW Foods CoQ10 400 mg — Coenzyme Q10: Speaking of mitochondria! Mitochondrial damage plays a role in dementia beyond protein aggregation. Impaired mitochondrial function disrupts neuronal energy supply, contributing long-term to neurodegenerative processes. CoQ10 is a key cofactor, supporting electron transport chain function and acting as an antioxidant to protect cells, potentially preserving brain function.

Final Thoughts

The listed products may seem numerous at first, and it’s worth dividing them into two groups: those recommended for prevention or very mild symptoms.

For Prevention:

For Therapeutic Purposes (Only with Physician Approval):

Contraindications

The following compounds are generally well combinable, but caution is required in certain conditions or with medications.

With anticoagulant therapy, medical consultation is needed before using:

  • resveratrol
  • DHA
  • green tea
  • CoQ10 (with warfarin)

In cases of bleeding tendency or before surgery:

  • resveratrol
  • DHA
  • green tea

With low blood pressure, dizziness, or weakness:

  • bacopa
  • CoQ10
  • resveratrol

With liver sensitivity:

  • green tea (EGCG)

With hormone-sensitive conditions:

  • resveratrol (weak phytoestrogen)

Avoid NOW Foods Brain Elevate in the following conditions:

  • anticoagulant therapy,
  • bleeding disorders,
  • epilepsy,
  • before surgery,
  • pregnancy, breastfeeding,
  • bradycardia,
  • Alzheimer’s medications, and
  • severe liver disease.

Additional caution is advised in:

  • fluctuating blood pressure,
  • sensitivity to multiple herbs,
  • low pulse, and
  • thyroid issues.

Furthermore, during breastfeeding or pregnancy, any supplement use requires medical consultation — though less relevant to dementia, it’s important to note.

Sources ⋙
  1. Li X, Feng X, Sun X, Hou N, Han F, Liu Y. Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2019. Front Aging Neurosci. 2022 Oct 10;14:937486. doi: 10.3389/fnagi.2022.937486. PMID: 36299608; PMCID: PMC9588915.
  2. https://www.thelancet.com/action/showCitFormats?doi=10.1016%2FS2468-2667%2821%2900249-8&pii=S2468-2667%2821%2900249-8
  3. Emmady PD, Schoo C, Tadi P. Major Neurocognitive Disorder (Dementia) [Updated 2022 Nov 19]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK557444/
  4. https://escholarship.org/content/qt77g8t63q/qt77g8t63q_noSplash_59d7fbd60fc063e6dba5c393fe7ea300.pdf
  5. Mehta RI, Schneider JA. Neuropathology of the Common Forms of Dementia. Clin Geriatr Med. 2023 Feb;39(1):91-107. doi: 10.1016/j.cger.2022.07.005. Epub 2022 Oct 18. PMID: 36404035; PMCID: PMC10013181.
  6. https://www1.racgp.org.au/ajgp/2023/august/pathophysiology-of-dementia
  7. Goel P, Chakrabarti S, Goel K, Bhutani K, Chopra T, Bali S. Neuronal cell death mechanisms in Alzheimer's disease: An insight. Front Mol Neurosci. 2022 Aug 25;15:937133. doi: 10.3389/fnmol.2022.937133. PMID: 36090249; PMCID: PMC9454331.
  8. Wang J, Dai L, Zhang Z. Protein aggregation in neurodegenerative diseases. Chin Med J (Engl). 2025 Nov 5;138(21):2753-2768. doi: 10.1097/CM9.0000000000003802. Epub 2025 Sep 16. PMID: 40960157; PMCID: PMC12574514.
  9. Sanders AE, Schoo C, Kalish VB. Vascular Dementia. [Updated 2023 Oct 22]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK430817/
  10. https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.13360
  11. Cheng, ST. Cognitive Reserve and the Prevention of Dementia: the Role of Physical and Cognitive Activities. Curr Psychiatry Rep 18, 85 (2016). https://doi.org/10.1007/s11920-016-0721-2
  12. https://bjsm.bmj.com/content/56/12/701
  13. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2841638
  14. https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667%2821%2900071-2/fulltext
  15. Stern Y. Cognitive reserve. Neuropsychologia. 2009 Aug;47(10):2015-28. doi: 10.1016/j.neuropsychologia.2009.03.004. Epub 2009 Mar 13. PMID: 19467352; PMCID: PMC2739591.
  16. https://link.springer.com/article/10.1007/s11065-021-09478-4
  17. https://www.frontiersin.org/journals/aging-neuroscience/articles/10.3389/fnagi.2024.1358992/full
  18. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0038268
  19. Dyall SC. Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA. Front Aging Neurosci. 2015 Apr 21;7:52. doi: 10.3389/fnagi.2015.00052. PMID: 25954194; PMCID: PMC4404917.
  20. M Mafham, S Parish, A Offer, G Buck, L Bowman, J Armitage, The ASCEND Study Group , Effects of omega-3 fatty acids on dementia and cognitive Impairment in the ASCEND trial, European Heart Journal, Volume 43, Issue Supplement_2, October 2022, ehac544.2434, https://doi.org/10.1093/eurheartj/ehac544.2434
  21. Vargas-Uricoechea, H.; Castellanos-Pinedo, A.; Urrego-Noguera, K.; Vargas-Sierra, H.D.; Pinzón-Fernández, M.V.; Barceló-Martínez, E.; Ramírez-Giraldo, A.F. Mindfulness-Based Interventions and the Hypothalamic–Pituitary–Adrenal Axis: A Systematic Review. Neurol. Int. 2024, 16, 1552-1584. https://doi.org/10.3390/neurolint16060115
  22. Pascoe, M. C., Thompson, D. R., & Ski, C. F. (2017). Yoga, mindfulness-based stress reduction and stress-related physiological measures: A meta-analysis. Psychoneuroendocrinology, 86, 152–168. https://doi.org/10.1016/j.psyneuen.2017.08.008
  23. https://www.frontiersin.org/journals/human-neuroscience/articles/10.3389/fnhum.2017.00315/full
  24. Paller KA, Voss JL. Memory reactivation and consolidation during sleep. Learn Mem. 2004 Nov-Dec;11(6):664-70. doi: 10.1101/lm.75704. PMID: 15576883; PMCID: PMC534694.
  25. Balsamo, F.; Berretta, E.; Meneo, D.; Baglioni, C.; Gelfo, F. The Complex Relationship between Sleep and Cognitive Reserve: A Narrative Review Based on Human Studies. Brain Sci. 2024, 14, 654. https://doi.org/10.3390/brainsci14070654
  26. Liu, H., Ye, M., & Guo, H. (2019). An updated review of randomized clinical trials testing the improvement of cognitive function of Ginkgo biloba extract in healthy people and Alzheimer’s patients. Frontiers in Pharmacology, 10, 1688. https://doi.org/10.3389/fphar.2019.01688
  27. Pagotto, G. L. O., Santos, L. M. O., Osman, N., et al. (2024). Ginkgo biloba: A leaf of hope in the fight against Alzheimer’s dementia: Clinical trial systematic review. Antioxidants, 13(6), 651. https://doi.org/10.3390/antiox13060651
  28. Park, K. C., Jin, H., Zheng, R., et al. (2020). Cognition enhancing effect of Panax ginseng in Korean volunteers with mild cognitive impairment: A randomized, double-blind, placebo-controlled clinical trial. Journal of Ginseng Research, 44(4), 599–607. https://pubmed.ncbi.nlm.nih.gov/32055589
  29. Lee, S., Jung, H. C., Sargent, M., & Kang, M. (2023). Acute effects of wild ginseng extract on exercise performance, cognitive function, and fatigue recovery: A randomized cross-over, placebo-controlled, double-blind study. International Journal of Traditional Medicine, 5(1), 5. https://doi.org/10.3390/ijtm5010005
  30. Aguree, S., Zolnoori, M., Atwood, T. P., & Owora, A. (2023). Association between choline supplementation and Alzheimer’s disease risk: A systematic review protocol. Frontiers in Aging Neuroscience, 15, 1242853. https://doi.org/10.3389/fnagi.2023.1242853
  31. Zeisel, S. H. (2017). Neuroprotective actions of dietary choline: Role of phosphatidylcholine in cognition. Nutrition Reviews, 75(9), 659–670. https://pmc.ncbi.nlm.nih.gov/articles/PMC5579609
  32. Mulargia, R., Ribaldi, F., Mutel, S., et al. (2024). Exploring the preventive effects of omega-3 polyunsaturated fatty acids supplementation on global cognition: A systematic review and meta-analysis. Clinical Trials in Nutrition, 9(3), 34. https://doi.org/10.3390/ctn9030034
  33. Kalamara, T. V., Dodos, K., Georgakopoulou, V., et al. (2025). Cognitive efficacy of omega-3 fatty acids in Alzheimer’s disease: A systematic review and meta-analysis. Biomedical Reports, 62, Article 1940. https://doi.org/10.3892/br.2025.1940
  34. Wang, Z., Zhu, W., Xing, Y., Jia, J., & Tang, Y. (2022). B vitamins and prevention of cognitive decline and incident dementia: A systematic review and meta-analysis. Nutrition Reviews, 80(4), 931–949. https://doi.org/10.1093/nutrit/nuab057
  35. Li, S., Guo, Y., Men, J., Fu, H., & Xu, T. (2021). The preventive efficacy of vitamin B supplements on the cognitive decline of elderly adults: A systematic review and meta-analysis. BMC Geriatrics, 21, 367. https://doi.org/10.1186/s12877-021-02253-3
  36. Zhao, R., Han, X., Zhang, H., et al. (2022). Association of vitamin E intake in diet and supplements with risk of dementia: A meta-analysis. Frontiers in Aging Neuroscience, 14, 955878. https://doi.org/10.3389/fnagi.2022.955878
  37. Kang, J. H., Cook, N., Manson, J., et al. (2006). A randomized trial of vitamin E supplementation and cognitive function in women. JAMA Internal Medicine, 166(22), 2462–2468. https://doi.org/10.1001/archinte.166.22.2462
  38. Hamid, M., Mansoor, S., Amber, S., & Zahid, S. (2022). A quantitative meta-analysis of vitamin C in the pathophysiology of Alzheimer’s disease. Frontiers in Aging Neuroscience, 14, 970263. https://doi.org/10.3389/fnagi.2022.970263
  39. Travica, N., Ried, K., Sali, A., Scholey, A., Hudson, I., & Pipingas, A. (2017). Vitamin C status and cognitive function: A systematic review. Nutrients, 9(9), 960. https://doi.org/10.3390/nu9090960
  40. Tang, S., Zhang, Y., Botchway, B. O. A., Wang, X., Huang, M., & Liu, X. (2025). Epigallocatechin-3-gallate inhibits oxidative stress through the Keap1/Nrf2 signaling pathway to improve Alzheimer disease. Molecular Neurobiology, 62, 3493–3507. https://doi.org/10.1007/s12035-024-04498-6
  41. Paul, F., Charité University Berlin. (2021). Sunphenon EGCG in the early stage of Alzheimer’s disease (SUN-AK). ClinicalTrials.gov Identifier: NCT00951834. https://clinicaltrials.gov/study/NCT00951834
  42. Kamboj, N., Sharma, S., & Kumar, R. (2025). Neuroprotective insights into epigallocatechin gallate (EGCG) for neurodegenerative disorders. Exploration of Neuroscience, 4, 100673. https://doi.org/10.37349/en.2025.100673
  43. Das, S. S., Gopal, P. M., Thomas, J. V., et al. (2023). Influence of CurQfen®-curcumin on cognitive impairment: A randomized, double-blinded, placebo-controlled study. Frontiers in Dementia, 2, 1222708. https://doi.org/10.3389/frdem.2023.1222708
  44. Small, G. W., UCLA. (2020). 18-Month study of memory effects of curcumin. ClinicalTrials.gov Identifier: NCT01383161. https://clinicaltrials.gov/study/NCT01383161
  45. Puranik, N., Kumari, M., Tiwari, S., Dhakal, T., & Song, M. (2025). Resveratrol as a therapeutic agent in Alzheimer’s disease: Evidence from clinical studies. Nutrients, 17(15), 2557. https://doi.org/10.3390/nu17152557
  46. Azargoonjahromi, A., & Abutalebian, F. (2024). Unraveling the therapeutic efficacy of resveratrol in Alzheimer’s disease: An umbrella review. Nutrition & Metabolism, 21, 15. https://doi.org/10.1186/s12986-024-00792-1
  47. Alzheimer’s Disease Cooperative Study (ADCS). (2016). Resveratrol for Alzheimer’s disease. ClinicalTrials.gov Identifier: NCT01504854. https://clinicaltrials.gov/study/NCT01504854
  48. Yassine, H. N., et al. (2020). Brain delivery of supplemental docosahexaenoic acid (DHA): A randomized placebo-controlled clinical trial. eBioMedicine, 59, 102883. https://doi.org/10.1016/j.ebiom.2020.102883
  49. Avallone, R., Vitale, G., & Bertolotti, M. (2019). Omega-3 fatty acids and neurodegenerative diseases: New evidence in clinical trials. International Journal of Molecular Sciences, 20(17), 4256. https://doi.org/10.3390/ijms20174256
  50. Castellanos-Perilla, N., Bordab, M. G., Aarsland, D., & Barreto, G. E. (2024). An analysis of omega-3 clinical trials and a call for personalized supplementation for dementia prevention. Expert Review of Neurotherapeutics, 24(3), 313–324. https://doi.org/10.1080/14737175.2024.2313547
  51. Yang, G., Wang, Y., Tian, J., & Liu, J. P. (2013). Huperzine A for Alzheimer’s disease: A systematic review and meta-analysis of randomized clinical trials. PLOS ONE, 8(9), e74916. https://doi.org/10.1371/journal.pone.0074916
  52. Friedli, M. J., & Inestrosa, N. C. (2021). Huperzine A and its neuroprotective molecular signaling in Alzheimer’s disease. Molecules, 26(21), 6531. https://doi.org/10.3390/molecules26216531
  53. Wanbangde Pharmaceutical Group. (2025). Clinical study to evaluate the efficacy and safety of Huperzine A controlled-release tablets in Alzheimer’s dementia. ClinicalTrials.gov Identifier: NCT07066826. https://clinicaltrials.gov/study/NCT07066826

Among our articles written by our nutrition expert, you'll find product reviews and helpful tips on healthy living and prevention.

Our most popular articles: